Σύγκριση μεθόδων
Εξετάστε τις επιλεγμένες μεθόδους δίπλα-δίπλα· οι γραμμές που διαφέρουν επισημαίνονται.
| Σχεδιασμός τυχαιοποιημένης ελεγχόμενης δοκιμής με διασταύρωση× | Προσαρμοστική Τυχαιοποιημένη Ελεγχόμενη Δοκιμή× | |
|---|---|---|
| Πεδίο | Πειραματικός Σχεδιασμός | Πειραματικός Σχεδιασμός |
| Οικογένεια | Process / pipeline | Process / pipeline |
| Έτος προέλευσης≠ | 1960s (Grizzle 1965 for statistical foundations); widely used in clinical research since the 1970s | 1980s–2000s (formalized; earlier sequential testing roots from Wald, 1947) |
| Δημιουργός≠ | Early formalized by statisticians including Bradford Hill and colleagues in clinical trials; theoretical framework developed by Grizzle (1965) and later Senn (2002) | Donald Berry and others; foundational adaptive trial methods developed through 1980s–2000s biostatistics literature |
| Τύπος≠ | Experimental within-subject design | Experimental design — adaptive variant of RCT |
| Θεμελιώδης πηγή≠ | Senn, S. (2002). Cross-over Trials in Clinical Research (2nd ed.). Wiley. ISBN: 978-0471496533 | Chow, S.-C., & Chang, M. (2008). Adaptive Design Methods in Clinical Trials. Chapman & Hall/CRC. ISBN: 978-1584887690 |
| Εναλλακτικές ονομασίες | crossover RCT, crossover trial, within-subject RCT, AB/BA crossover design | Adaptive RCT, Response-adaptive RCT, Adaptive clinical trial, Platform trial |
| Συναφείς≠ | 5 | 6 |
| Σύνοψη≠ | A crossover randomized controlled trial (crossover RCT) is an experimental design in which each participant receives all study interventions in a randomized sequence, separated by a washout period. Because every participant serves as their own control, within-subject variability is eliminated from the treatment comparison, yielding greater statistical power per participant than a parallel-group RCT of equal size. | An adaptive randomized controlled trial (adaptive RCT) is an experimental design in which pre-specified rules allow modifications to the trial while it is ongoing — such as changing allocation ratios, dropping underperforming arms, or stopping early for efficacy or futility — based on accumulating interim data. These adaptations are planned before the trial starts and governed by statistical rules to preserve Type I error control and validity. |
| ScholarGateΣύνολο δεδομένων ↗ |
|
|